Oxisopred
| Oxisopred | |
|---|---|
| Oxisopred.svg | |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Oxisopred is a synthetic glucocorticoid used in the treatment of various inflammatory and autoimmune conditions. It is part of the corticosteroid class of medications, which are known for their potent anti-inflammatory and immunosuppressive properties.
Pharmacology[edit]
Oxisopred functions by mimicking the effects of cortisol, a natural hormone produced by the adrenal cortex. It binds to glucocorticoid receptors in the body, leading to a decrease in the production of inflammatory mediators such as cytokines and prostaglandins. This action helps reduce inflammation and modulate the immune response.
Medical Uses[edit]
Oxisopred is indicated for the management of conditions such as:
Side Effects[edit]
Like other corticosteroids, Oxisopred can cause a range of side effects, especially with long-term use. Common side effects include:
Mechanism of Action[edit]
Oxisopred exerts its effects by entering cells and binding to glucocorticoid receptors in the cytoplasm. This complex then translocates to the cell nucleus, where it influences the transcription of specific genes that regulate inflammatory and immune responses.
Administration[edit]
Oxisopred is typically administered orally, but it can also be given via intravenous or intramuscular routes depending on the clinical situation. The dosage and duration of treatment are tailored to the individual patient's needs and the specific condition being treated.
